March 4, 2015 | InsuLine Medical CEO Mike Netz resigned from his position after the company’s share price dropped seventy percent. The big dip the company’s share price occurred after the company announced that it was unable to secure the proper insurance clearance for its product for the treatment of diabetes in Germany. The company reports that Netz will be temporarily replaced by Eyal Levy, a member of the company’s board. Insuline Medical was founded in 2007 and is headquartered in Petah Tikvah.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments